Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 19, 2020 6:21am
288 Views
Post# 31168070

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:To anyone thinking about investing in this company

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:To anyone thinking about investing in this company

Liminal went through 6 months of CMC testing at their Ryplazim manufacturing plant as part of BLA after years and years of producing in Laval for over 5000 doses of administered Ryplazim. Any Rockville expertise had been transferred long ago to Laval. Pierre and Lynne did not make Ryplazim. That's for the manufacturing experts in Laval. 


4Justice wrote: Charm...that's tthe truth.
They can no longer produce Ryplazim in Laval because they no longer have the technologicval support of specialists from Rockvile. It was them, when PLI was in pertenership with American Red Cross who developped the PPPS technology that was un ique and have the capability to filter plasminogene. IVIG, Inter Alpha and many others hight valuable and rare proteins.

They fired Pierre Laurin, Lyne Gagnon and all the team in Rockville. I'm sure Patrick Sartore, lawyer, and Mss Daniels in Cambridge will solve this little problem.

Do your DD

 

<< Previous
Bullboard Posts
Next >>